Diabetes Mellitus News and Research

RSS
Diabetes mellitus is a severe and debilitating chronic disease that develops in nearly 5 percent of the world’s population. People with this disease have a shortage of insulin or a reduced ability to use insulin, the hormone regulating blood glucose levels, which is normally produced by the pancreas. In the United States alone, an estimated 18 million people have diabetes, and each year about 1 million Americans are diagnosed with the disease. It is the sixth leading cause of death in the US and is responsible for over 200,000 deaths a year. Insulin-dependent (type I) diabetes accounts for around 10% of diabetics. For those patients, suffering from an inability of their pancreas to produce insulin, the only practical treatment possible is regular insulin replacement by multiple daily injections. Transplantation of a pancreas or pancreatic tissue would be beneficial to millions of such patients in that it would restore their normal ability to produce self insulin. Transplantation of human pancreas or pancreatic islets is a practiced and time-honored such therapeutic approach, but is extremely limited by the severe shortage of human donor organs. Tissera's R&D efforts in this domain are directed towards the development of a universally available and reliable source of animal fetal donor pancreatic precursor tissue, suitable for transplantation and eventual normal structural and functional growth in human diabetics.
Assessing the real risk of heart disease in young people with low short-term risks

Assessing the real risk of heart disease in young people with low short-term risks

Cell transplantation and diabetes: New sites, new devices

Cell transplantation and diabetes: New sites, new devices

Stroke telemedicine assessed

Stroke telemedicine assessed

Half of people 50 years and younger with low 10-year risk of CVD have high lifetime risk

Half of people 50 years and younger with low 10-year risk of CVD have high lifetime risk

Diabetes associated with different types of brain injury in patients with dementia

Diabetes associated with different types of brain injury in patients with dementia

Lilly receives complete response letter for Olanzapine LAI for treatment of schizophrenia

Lilly receives complete response letter for Olanzapine LAI for treatment of schizophrenia

Phase 3 trial begins for Gammagard liquid plus rHuPH20 in primary immunodeficiency patients

Phase 3 trial begins for Gammagard liquid plus rHuPH20 in primary immunodeficiency patients

Pre-existing diabetes for persons diagnosed with cancer associated with increased risk of death

Pre-existing diabetes for persons diagnosed with cancer associated with increased risk of death

Psoriasis sufferers more likely to have higher levels of leptin

Psoriasis sufferers more likely to have higher levels of leptin

Neither vitamin E nor selenium reduce risk of prostate cancer

Neither vitamin E nor selenium reduce risk of prostate cancer

Cases of major eye disease projected to increase among diabetics

Cases of major eye disease projected to increase among diabetics

A new approach improves prioritization of disease-associated SNPs

A new approach improves prioritization of disease-associated SNPs

Genetic variation for persons with diabetes linked to greater risk of coronary artery disease

Genetic variation for persons with diabetes linked to greater risk of coronary artery disease

First study to look at health of centenarian offspring

First study to look at health of centenarian offspring

Pelvic girdle syndrome linked to diabetes

Pelvic girdle syndrome linked to diabetes

New study highlights potential for cost effective NHS policy

New study highlights potential for cost effective NHS policy

Drug-eluting better than bare metal stents in diabetics

Drug-eluting better than bare metal stents in diabetics

Sleep disorders linked to eye disease

Sleep disorders linked to eye disease

Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes

Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes

Diabetics more likely to lose their vision

Diabetics more likely to lose their vision